| Financial instrument | ISIN code | Nature of transaction | Linked to a share option programme | Volume | Unit | Price | Currency code | Transaction date | Trading venue |
|---|---|---|---|---|---|---|---|---|---|
| NeuroVive Pharmaceutical AB | SE0002575340 | Acquisition | 6,000 | Quantity | 3.35 | SEK | 25/11/2016 | NASDAQ STOCKHOLM AB | |
| NeuroVive Pharmaceutical AB | SE0002575340 | Acquisition | 25,000 | Quantity | 3.45 | SEK | 25/11/2016 | NASDAQ STOCKHOLM AB | |
| NeuroVive Pharmaceutical AB | SE0002575340 | Acquisition | 4,000 | Quantity | 3.40 | SEK | 28/11/2016 | NASDAQ STOCKHOLM AB |
| Financial instrument | ISIN code | Nature of transaction | Transaction date | Trading venue | Volume | Weighted average price |
|---|---|---|---|---|---|---|
| NeuroVive Pharmaceutical AB | SE0002575340 | Acquisition | 25/11/2016 | NASDAQ STOCKHOLM AB | 31,000 (Quantity) | 3.43064516 SEK |
| NeuroVive Pharmaceutical AB | SE0002575340 | Acquisition | 28/11/2016 | NASDAQ STOCKHOLM AB | 4,000 (Quantity) | 3.40 SEK |
| Total: | 35,000 |